Journal article
Humoral and cellular responses raised against the human HER2 oncoprotein are cross-reactive with the homologous product of the new proto-oncogene, but do not protect rats against B104 tumors expressing mutated neu.
- Abstract:
-
The neu proto-oncogene encodes a plasma membrane protein belonging to the epidermal growth factor receptor family. The cell line B104, derived from BDIX rat neuroblastoma, carries a point mutation in neu, and forms a tumor when injected into these rats. The human homologue of the neu oncogene (here called HER2) is overexpressed in certain types of cancer. Rats were immunized with HER2 protein (HER2) to investigate a possible cross-reaction between the homologous proteins which could protect t...
Expand abstract
- Publication status:
- Published
Actions
Authors
Bibliographic Details
- Journal:
- Cancer immunology, immunotherapy : CII
- Volume:
- 42
- Issue:
- 3
- Pages:
- 179-184
- Publication date:
- 1996-03-01
- DOI:
- EISSN:
-
1432-0851
- ISSN:
-
0340-7004
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:481697
- UUID:
-
uuid:1d85bf95-bc5b-45db-82b4-14800257262a
- Local pid:
- pubs:481697
- Source identifiers:
-
481697
- Deposit date:
- 2014-08-29
Terms of use
- Copyright date:
- 1996
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record